Home » Glucose Meter Market
Glucose Meter Market
Published date: Nov 2021 •Formats:
Request Sample Schedule a Call

Global Glucose Meter Market By Type (Hospital glucose meters, Blood testing with meters using test strips, Noninvasive meters, and Continuous glucose monitors), By Application (Medical, and Home Care), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • Published date: Nov 2021
  • Report ID: 15309
  • Number of Pages: 233
  • Format:
  • keyboard_arrow_up
    • 1. Glucose Meter Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Glucose Meter Market Overview
      • 3.1. Glucose Meter Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Glucose Meter Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Glucose Meter Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Hospital glucose meters
      • 4.4. Blood testing with meters using test strips
      • 4.5. Noninvasive meters
      • 4.6. Continuous glucose monitors
    • 5. Global Glucose Meter Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Glucose Meter Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Medical
      • 5.4. Home Care
    • 6. Global Glucose Meter Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Glucose Meter Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Glucose Meter Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Glucose Meter Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Glucose Meter Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Glucose Meter Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Glucose Meter Market Competitive Landscape, Market Share Analysis, and Company Profiles
        • 7.1. Market Share Analysis
        • 7.2. Company Profiles
        • 7.3. Roche
          • 7.3.1. Company Overview
          • 7.3.2. Financial Highlights
          • 7.3.3. Product Portfolio
          • 7.3.4. SWOT Analysis
          • 7.3.5. Key Strategies and Developments
        • 7.4. Johnson & Johnson
          • 7.4.1. Company Overview
          • 7.4.2. Financial Highlights
          • 7.4.3. Product Portfolio
          • 7.4.4. SWOT Analysis
          • 7.4.5. Key Strategies and Developments
        • 7.5. Bayer
          • 7.5.1. Company Overview
          • 7.5.2. Financial Highlights
          • 7.5.3. Product Portfolio
          • 7.5.4. SWOT Analysis
          • 7.5.5. Key Strategies and Developments
        • 7.6. Abbott
          • 7.6.1. Company Overview
          • 7.6.2. Financial Highlights
          • 7.6.3. Product Portfolio
          • 7.6.4. SWOT Analysis
          • 7.6.5. Key Strategies and Developments
        • 7.7. OMRON Healthcare India Pvt Ltd
          • 7.7.1. Company Overview
          • 7.7.2. Financial Highlights
          • 7.7.3. Product Portfolio
          • 7.7.4. SWOT Analysis
          • 7.7.5. Key Strategies and Developments
        • 7.8. ARKRAY, Inc.
          • 7.8.1. Company Overview
          • 7.8.2. Financial Highlights
          • 7.8.3. Product Portfolio
          • 7.8.4. SWOT Analysis
          • 7.8.5. Key Strategies and Developments
        • 7.9. Grace Medical
          • 7.9.1. Company Overview
          • 7.9.2. Financial Highlights
          • 7.9.3. Product Portfolio
          • 7.9.4. SWOT Analysis
          • 7.9.5. Key Strategies and Developments
        • 7.10. B.Braun Medical Inc.
          • 7.10.1. Company Overview
          • 7.10.2. Financial Highlights
          • 7.10.3. Product Portfolio
          • 7.10.4. SWOT Analysis
          • 7.10.5. Key Strategies and Developments
        • 7.11. i-SENS
          • 7.11.1. Company Overview
          • 7.11.2. Financial Highlights
          • 7.11.3. Product Portfolio
          • 7.11.4. SWOT Analysis
          • 7.11.5. Key Strategies and Developments
        • 7.12. Infopia Co Ltd.
          • 7.12.1. Company Overview
          • 7.12.2. Financial Highlights
          • 7.12.3. Product Portfolio
          • 7.12.4. SWOT Analysis
          • 7.12.5. Key Strategies and Developments
        • 7.13. Hainice Medical Inc
          • 7.13.1. Company Overview
          • 7.13.2. Financial Highlights
          • 7.13.3. Product Portfolio
          • 7.13.4. SWOT Analysis
          • 7.13.5. Key Strategies and Developments
        • 7.14. Mendor
          • 7.14.1. Company Overview
          • 7.14.2. Financial Highlights
          • 7.14.3. Product Portfolio
          • 7.14.4. SWOT Analysis
          • 7.14.5. Key Strategies and Developments
        • 7.15. All Medicus Co Ltd.
          • 7.15.1. Company Overview
          • 7.15.2. Financial Highlights
          • 7.15.3. Product Portfolio
          • 7.15.4. SWOT Analysis
          • 7.15.5. Key Strategies and Developments
        • 7.16.77 Elektronika Kft.
          • 7.16.1. Company Overview
          • 7.16.2. Financial Highlights
          • 7.16.3. Product Portfolio
          • 7.16.4. SWOT Analysis
          • 7.16.5. Key Strategies and Developments
        • 7.17. Delta
          • 7.17.1. Company Overview
          • 7.17.2. Financial Highlights
          • 7.17.3. Product Portfolio
          • 7.17.4. SWOT Analysis
          • 7.17.5. Key Strategies and Developments
        • 7.18. OK Biotech Co Ltd.
          • 7.18.1. Company Overview
          • 7.18.2. Financial Highlights
          • 7.18.3. Product Portfolio
          • 7.18.4. SWOT Analysis
          • 7.18.5. Key Strategies and Developments
        • 7.19. MEDISANA AG
          • 7.19.1. Company Overview
          • 7.19.2. Financial Highlights
          • 7.19.3. Product Portfolio
          • 7.19.4. SWOT Analysis
          • 7.19.5. Key Strategies and Developments
        • 7.20. FIFTY 50
          • 7.20.1. Company Overview
          • 7.20.2. Financial Highlights
          • 7.20.3. Product Portfolio
          • 7.20.4. SWOT Analysis
          • 7.20.5. Key Strategies and Developments
        • 7.21. Nova Biomedical
          • 7.21.1. Company Overview
          • 7.21.2. Financial Highlights
          • 7.21.3. Product Portfolio
          • 7.21.4. SWOT Analysis
          • 7.21.5. Key Strategies and Developments
        • 7.22. Oak Tree Health
          • 7.22.1. Company Overview
          • 7.22.2. Financial Highlights
          • 7.22.3. Product Portfolio
          • 7.22.4. SWOT Analysis
          • 7.22.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Glucose Meter Market
  • 15309
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (47)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore